Lotte Central Research Institute Signs Microbiome Research MOU with Senizen

Park Jung-woong, CEO of Senizen (left), and Yang Si-young, Executive Director of Lotte Central Research Institute, are taking a commemorative photo after signing a business agreement on microbiome analysis and joint research on the 20th.

[Asia Economy Reporter Seungjin Lee] Lotte Central Research Institute announced on the 21st that it has signed a business agreement with Senigen for the purpose of "mutual development promotion through microbiome analysis and joint research."

Through this agreement, both companies mutually agreed to maximize synergy effects through gradual partnership in the field of microbiome analysis and research via organic business cooperation.

To this end, they agreed to establish a cooperative system to ▲ mutually share comparative analysis data of gut microbiomes between naturally delivered and cesarean-delivered infants through the intake of Pasteur formula containing B. longum probiotics ▲ actively discover areas of mutual cooperation during microbial analysis processes ▲ continuously build partnerships in the microbiome research field, and actively support other necessary business and project cooperation for mutual development.

Si-young Yang, Executive Director of Lotte Central Research Institute, stated, “Through this business cooperation, we hope to actively leverage the strengths of both Lotte Central Research Institute and Senigen to expand research related to microbiome analysis and scientifically prove the excellence of related products such as formula.”

This content was produced with the assistance of AI translation services.